Proteomics set for growth, says Kardinia |
Tweet | ![]() |
<p><strong>Lex Hall: </strong>Hi, I'm Lex Hall for Morningstar. Kristiaan Rehder is Portfolio Manager at the Bennelong Kardinia Absolute Return Fund. We're here today to talk about some top performers in the fund.</p>
<p>Welcome again to Morningstar, Kristiaan.</p>
<p><strong>Kristiaan Rehder: </strong>Hi, Lex. Thanks for having me.</p>
<p><strong>Hall: </strong>Now, there's a few interesting pretty juicy stocks in your fund, which have done pretty well. And the first of them is a company that I've certainly never heard of, but it's done very, very well. It's called Proteomics. The ticker is PIQ. Tell us how you discovered it and what it does, and can they keep it up.</p>
<p><strong>Rehder: </strong>Well, Proteomics, I'm not surprised you haven't heard about it, it's on the smaller end of the spectrum, not many people have. It's got a market cap of about $150 million. It's actually of all places is based in Perth in WA. It is a medical device company which is somewhat unusual for Perth. You usually associated Perth with resources. But they do have a number of very intersesting biotech companies and this is certainly one of them.</p>
<p>Look, we all know that diabetes is a growing issue, I guess, globally. Most sufferers of diabetes, in fact 40 per cent of diabetics, will end up developing what's referred to as diabetic kidney disease. And so, the cost to health insurance, the cost to governments globally is quite enormous. So, 9 out of 10 DKD sufferers don't suffer from any symptoms. So, they suffer without any knowledge, I guess, of the symptom or the inflections that they have. And what Proteomics has developed, they developed a device that is able to predict DKD four years in advance with around an 86 per cent accuracy. So, it is a game changer. And just to give you an indication of how expensive it is to treat DKD—the US Medicare system spends around 40 per cent of its total budget to try through dialysis and kidney transplants to treat diabetic kidney disease.</p>
<p><strong>Hall: </strong>So, is that a stock you hold onto, or do you trim because it's had such a stellar rise, hasn't it?</p>
<p><strong>Rehder: </strong>It has had a stellar rise. I mean, it's a largely undiscovered company. The one thing about this company, it's got an enormous total addressable market size. So, there is approximately 460 diabetics in the US and globally at the moment. We expect that number to grow to around 700 by 2045. That's tremendous growth. It's a company that is right on the precipice of their sales. So, it's got CE Mark approval, which is the equivalent of FDA approval for Europe. There is tremendous upside. We see a clear pathway to around a million tests in next three to four years, which will see the market cap expand to multiples of what it is today. So, it's a long way of answering your question. We're quite happy holders. Even though it's been a strong performer, we think it's got a long way to go.</p>
<p><strong>Hall: </strong>That's good. Well, we're not too late then?</p>
<p><strong>Rehder: </strong>No.</p>
<p><strong>Hall: </strong>Second name on the list today is one that I've heard of and I imagine a lot of people will have is the online bookmaker PointsBet. It's the only one that offers more markets on the NBA, AFL and NRL, I think, than any other bookmaker in the world. When did you get in and what else do you see in it?</p>
<p><strong>Rehder: </strong>Yeah. Look, we've been in PointsBet for over a year. It's a reasonably new company. It only listed back in 2019. It's based in Australia, but it's got massive ambitions to enter the US. The US is well behind Australia in terms of online gambling and the reason for that is that they had a federal law that was recently struck down back in 2018 that prevented online gambling. With the striking down of that law it's now up to the states as to whether they allow it or not. So far, 20 states have opened up their markets to online gambling. That allows approximately 20 per cent of the US population access. The Americans are sports mad.</p>
<p><strong>Hall: </strong>It's hard to believe, isn't it, that they would sort of put on those kinds of curbs on online gaming.</p>
<p><strong>Rehder: </strong>Yeah, it is surprising, and I think one of the motivating factors, I think, for states to legalise gambling is just the fact that many of them are so indebted and they're all looking for revenue streams. And this is low hanging fruit for many of those.</p>
<p><strong>Hall: </strong>I see.</p>
<p><strong>Rehder: </strong>It is a sports mad country. We think Australians are sports mad; the Americans are equally as so. The US market, we've seen estimates for online gambling at around $17 billion. I almost fell off my chair when I was reading the investment presentation of a major competitor of sports bet, DraftKings, only a couple of weeks ago, and they were estimating that the market is more like $70 billion. So, it's a tremendous market opportunity for these guys. They are certainly well placed looking to achieve 10 per cent market share into the US and they are on track to achieve that.</p>
<p><strong>Hall: </strong>OK. Fantastic. So, that's PointsBet. PBH is the ticket. And finally, Kristiaan, a name, pretty much a household name in Australia, BlueScope Steel.</p>
<p><strong>Rehder: </strong>Yeah. Well, as you see, I've kind of taken you down the path of a medical device company, a tech company and now we're going through the (old industry). But BlueScope is a $9.5 billion company. It's well understood. It's got 50 per cent of its revenues derived from Australia. It's got 30 per cent derived from North America. It is in a terrific position at the moment. It's got a very strong balance sheet, $300 million cash on its balance sheet. It has a free cash flow yield at the moment of about 7.5 per cent, which we think is particularly attractive. It's just upgraded earnings 3 times in the half. We think it's due for another upgrade before the full year results. The reason we say that is steel industry in the US is really booming. There is strong demand for steel and that's seeing a big increase in steel spreads. You're the automotive industry really bounce back. The US housing market is flying so as the Australian market. You're seeing tremendous investment in ecommerce logistics, warehouses and government stimulus. And so, you've got this demand equation which is firing on all pistons.</p>
<p>And then, on the supply side, you've had serious consolidation over the last 20 years. We're very optimistic on BlueScope. Currently, steel spread is around $800 a ton. Their guidance was predicated on steel spreads of about $610 a ton. So, it's a big gap there that will need to get bridged. Just to give you an idea, every $50 increments in the steel spread translates to about $140 million to EBIT in their US business. So, they will either beat their numbers, I think, in the full results or they will come up with another earnings upgrade in the next three or four months.</p>

19/05/2022 Local investors were spooked after US retail giants Target and Walmart plummeted overnight as rising prices hit margins and inventory.

19/05/2022 On his recent visit to Australia, Morningstar's global chief investment officer Dan Kemp talks investing narratives, confronting the growing list of reasons to be concerned about markets and sustainable investing.

19/05/2022 Worries about inflation’s toll on earnings sparks Wednesday’s 4% plunge, but stocks are now far undervalued.

18/05/2022 One of the big themes of the year has been the value comeback. What is behind this resurgence after a pretty dismal period, and should your portfolio be tilting in its direction?

11/05/2022 Here's what investors who are worried about a recession should consider today.

11/05/2022 Morningstar analysts have identified TPG telecom as the most undervalued telecom stocks in the ASX 200 detailing multiple catalysts for earnings recovery and growth.

29/04/2022 Exclusive: Hermitage Capital Management CEO Bill Browder talks Putin, Russia, and the next six months for Ukraine

28/04/2022 Inflation, rising interest rates, geopolitical risks, and other things to keep your eye on.

27/04/2022 Morningstar's analyst talks about the Buffett's recent deals, what the stock is worth, and whether Berkshire will pay a dividend any time soon.

31/03/2022 Supply disruptions following Russia's invasion of Ukraine are forcing analysts to consider the possibility elevated prices persist.

30/03/2022 Rising interest rates, strong economic growth and cheaper valuations are driving banking stocks ahead of the broader market.

28/03/2022 Where are entertainment and streaming services headed?

24/03/2022 Problems in global supply chains are an opportunity for WiseTech as its logistics company customers move to replace old software.

23/03/2022 Markets focused on floods and bushfires are missing how insurers are cutting costs, doing more digitally and are looking down the barrel of a lift in investment income.

17/03/2022 Morningstar Investment Management's global CIO Dan Kemp explains why well-intentioned investors desperate for peace in Europe are making dangerous market calls

15/03/2022 Knowledge of the local market, strong branding and a growing subscription service should see the undervalued retailer retain market share in the rapidly growing online sales category, says Roy Van Keulen.

08/03/2022 Higher inflation, rising interest rates and booming commodity markets are driving a major rotation away from the post-pandemic winners, says Tim Murphy, Morningstar director of manager selection.

03/03/2022 Regulators are likely to be less lenient now the buy-now-pay-later sector is part of the fabric of Australian payments.

23/02/2022 Strong commodity prices, cheap valuations and a head start on interest rate hikes means emerging markets are set for strength, says Dr. Joseph Lai of Ox Capital.

23/02/2022 A belligerent speech from a president signalled the start of the latest phase of Russian agression last night, causing markets to wobble and investors to wonder.

15/02/2022 In an extended interview, Morningstar's Peter Warnes discusses the bear market in US technology stocks, interest rates and growth and his approach to investing outside the US and Australia.

13/02/2022 Morningstar equity analyst Shaun Ler explains why he see valuation upside high for MFG even as shares lose steam.

31/01/2022 The Chinese lunar year is almost over, and what a ride it's been. Morningstar speaks to JPMorgan Asset Management strategist Mike Bell about what's ahead.

23/01/2022 Christine Benz discusses how investors should handle the turmoil, whatever the life stage.

18/01/2022 Empty shelves will negatively impact supermarkets in the second half of fiscal 2022 but the impact on long-term earnings is minimal, says Morningstar analyst Johannes Faul.

17/01/2022 Bank earnings, house prices and China risk: Our experts and analysts discuss what they've got their eyes on in 2022.

24/12/2021 Our experts and analysts weigh in on what mattered for investors last year.

21/12/2021 New products, lower fees and a portfolio of undervalued stocks set to help the fund manager right the ship.

10/12/2021 And how does it match up against gold?

10/12/2021 Australian miners to be among the last standing as coal use fades.

08/12/2021 Rebalancing your portfolio is one of those beneficial habits that’s easy to let slide. But year-end is an ideal time to check how your portfolio is tracking against your target asset allocation.

03/12/2021 The gold-rated fund manager shares three ideas with long-term potential.

01/12/2021 Long-term investor sees opportunities where businesses are moving towards a zero-carbon future faster than governments.

30/11/2021 To understand your fund, get to know its underlying index.

29/11/2021 These companies are set to profit from the move to clean energy, says Lazard.

24/11/2021 The results of the COP26 climate summit suggest coal demand is likely to persist for longer than expected.

17/11/2021 And how investors can protect their portfolios.

08/11/2021 Morningstar thinks these moaty companies will remain resilient in the face of inflation and ongoing supply chain challenges.

05/11/2021 Morningstar maintains fair value despite a fall in margins and slower progress on cost reductions.

19/10/2021 These new US-listed exchange-traded funds will invest in bitcoin futures, not bitcoin itself.

15/10/2021 The ESG outperformance narrative is flawed, new research shows.

06/10/2021 Investors may need to hold more growth assets over the coming years, says Morningstar's Jody Fitzgerald.

01/10/2021 And how G8 Education and Link Administration are positioned for long-term success.

30/09/2021 What Reporting Season August 2021 told investors about the health of the financials sector.

28/09/2021 a2 milk is an opportunity to be greedy when others are fearful.

23/09/2021 Covid's winners and losers are returning to their prior trajectories.

21/09/2021 Sequence-of-returns risk matters for both retirees and savers. Here's why.

20/09/2021 Analysts expect the sector to recover to pre-Covid trading levels once borders reopen.

15/09/2021 Rising customer deposits and access to cheap funding helped Australia's banks stave off net interest margin pressure, but analysts see warning signs.

14/09/2021 Morningstar's Hortense Bioy on how to spot greenwashing and how to avoid it.

13/09/2021 Utilities and infrastructure names battle the impact of covid as private equity and pension funds circle.

10/09/2021 Hydrocarbons poised for a comeback.

09/09/2021 Providers have lifted prices after years of a debilitating chase for subscribers at all costs , says Morningstar's Brian Han.

08/09/2021 What shorting ETFs means for long-term investors.

07/09/2021 Morningstar senior analyst Grant Slade says Brambles secular growth trend is intact despite nearterm headwinds. He discusses results from the building and construction materials sector.

03/09/2021 Miners bask in the glow of iron ore prices while bargains remain in coal.

23/08/2021 Post-merger Woodside would be well positioned to deliver on the value we've seen for a long time, say Morningstar analysts.

16/08/2021 But the sector lacks uniformity, says Morningstar's Christopher Franz.

11/08/2021 Higher wholesale electricity prices bode well for AGL, according to Morningstar senior equities analyst Adrian Atkins.

11/08/2021 Morningstar FundInvestor editor Russ Kinnel describes some direct and indirect hedges for inflation protection.

10/08/2021 Copper and iron ore have benefited materially from China’s stimulus and the developed world recovery. But Morningstar analyst Mat Hodge see these benefit as transitory.

05/08/2021 We believe the transaction has a high chance of succeeding.

03/08/2021 The industry still has significant growth potential.

03/08/2021 Is one of the biggest sponsors of the Olympics positioned for an all-electric future?

23/07/2021 Morningstar's Lex Hall talks micro-cap stock picks with Carlos Gil, chief investment officer at Microequities Asset Management.

22/07/2021 Mornngstar's Lex Hall catches up with Carlos Gil, chief investment officer at Microequities Asset Management.

21/07/2021 The head of Australian small and mid-cap stocks at First Sentier Investors has her eye on ARB, Breville and IDP Education.

20/07/2021 The strong performances of global stock markets in 2020–21 are unlikely to be repeated in the coming year says Morningstar's Peter Warnes.

12/07/2021 Morningstar equity analysts warn that equities remain overvalued despite Australia's strong economic recovery.

08/07/2021 Private equity is an exciting area for investors, with lots of hotly-tipped stocks. But there are risks to be aware of, says Pitchbook analyst Dylan Cox.

08/07/2021 Warryn Robertson is looking at French infrastructure, retail pharmacy and tax services.

06/07/2021 Australia's largest banks have excess capital because they cut dividends, were more conservative on lending, divested assets and raised equity last year. Morningstar's Nathan Zaia thinks most of it should be returned to shareholders.

02/07/2021 PEXA burst onto the ASX this week in the biggest float since 2019. Morningstar's Gareth James gives his take on the company's future growth prospects.

30/06/2021 Iron ore prices have been on a tear, boosting the profits of Australia's top miners. How did we get here and is the only way up? Lex Hall sits down with Morningstar's Mat Hodge.

28/06/2021 Morningstar has recently initiated coverage of a food delivery app and a consumer finance product.

24/06/2021 Meeting the deluge of demand is the biggest task for US companies, says Bell Asset Management's Ned Bell.

22/06/2021 Are there still opportunities in the biotech sector now the covid-19 vaccine roll out is underway? We ask International Biotechnology Trust manager Ailsa Craig

21/06/2021 Morningstar's director of Asia equity research is confident the e-commerce giant will bounce back.

18/06/2021 A wide moat and attractive dividend potential are among the key takeaways of Woolworth's decision to demerge from the liquor and hospitality group.

15/06/2021 Lazard Asset Management's Warryn Robertson explains how companies in the Global Equity Franchise fund have adjusted to covid, and assesses the threat of rising inflation.

11/06/2021 Magellan's Craig Wright tells Emma Rapaport why it is leading the charge in the active ETF arena and how its global equity product works.

10/06/2021 Callum Burns of ICE Investors explains his conviction in pharmaceutical distributor Ebos, PSC Insurance Group, and elite sports analytics provider Catapult.

09/06/2021 Callum Burns explains how ICE Investors identifies companies with original products and sticky customer bases.

08/06/2021 They’re building an empire.

07/06/2021 A year ago the oil price went negative. How have oil giants handled the past 12 months and what's the outlook from here? Morningstar analyst Allen Good explains.

04/06/2021 As the investment world goes crazy for crypto, Morningstar Investment Management's Dan Kemp explains what to consider before putting it in your portfolio

03/06/2021 The airline sector is set to recover as international travel resumes. Morningstar analysts think Wizz Air offer the best opportunity among low-cost carriers.

28/05/2021 4D Infrastructure's Sarah Shaw outlines the investment case for Spanish multinationals Cellnex, and Iberdrola, and the potential of Mexican airports.

28/05/2021 The SEC continues to sort out its regulatory concerns.

27/05/2021 We’re raising our fair value as sales hit new highs—but investors need to put it in perspective, says Andrew Willis.

25/05/2021 Covid-19 has enhanced rather than impeded the future for global infrastructure, says Sarah Shaw of 4D Infrastructure.

24/05/2021 Tribeca's Jun Bei Liu also explains why she sees opportunity in sleep apnea specialist ResMed as well as Treasury Wine Estates.

19/05/2021 American Century Investment's Patricia Ribeiro sees growth in Chinese battery technology, biologics, and building materials in Latin America.

18/05/2021 Robotics is a fast-growing area of tech, creating opportunities in medical, logistics and life sciences sectors and much more.

18/05/2021 Square's Bitcoin purchase is more marketing than operations

10/05/2021 If Elon Musk ends up delivering, we might need to raise our fair value to US$1500 a share.

07/05/2021 Banks and resources are poised to deliver dividends, and Treasury Wine Estates and BNPL are worth a look, says Jun Bei Liu of Tribeca's Alpha Plus long/short fund.

05/05/2021 Digital banking, ecommerce and 5G are among the key trends set for rapid growth, says Patricia Ribeiro of American Century Investments.

04/05/2021 Analysts have made changes to the fixed interest, property, cash and equity allocations of Morningstar's Model ETF Portfolios to take advantage of the current market environment. They've also refreshed some of the funds in the portfolio.

30/04/2021 The stock market and the economy are not the same. Here's why.